Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | BARUGEL, MARIO |
| Género | Hombre |
| Área Principal WOS | Public, Environmental & Occupational Health; Pharmacology & Pharmacy; Medicine, Research & Experimental; |
| Afiliación Principal | Tecnofarma |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Public, Environmental & Occupational Health | 1 |
| Pharmacology & Pharmacy | 1 |
| Medicine, Research & Experimental | 1 |
| Scopus | #Pub |
|---|
| SciELO | #Pub |
|---|
| Título | Año | Citas | Tipo | Revista | Indexada |
|---|---|---|---|---|---|
| Ras Mutation Prevalence Among Patients With Metastatic Colorectal Cancer: A Meta Analysis Of Real World Data | 2017 | 22 | artículo de investigación | Biomarkers In Medicine | WoS Scopus |
| An Estimation Of Ras Mutation Prevalence Amongst Patients With M Crc Using A Meta Analytical Approach | 2016 | 0 | resumen de reunión | Pharmacoepidemiology And Drug Safety | WoS Scopus |
| Palabra Clave | #Pub |
|---|---|
| nras | 1 |
| wild-type | 1 |
| real world | 1 |
| ras | 1 |
| quality | 1 |
| prevalence | 1 |
| patterns | 1 |
| pathology | 1 |
| panitumumab | 1 |
| anti-egfr | 1 |
| metastatic colorectal cancer | 1 |
| mcrc | 1 |
| kras | 1 |
| fluorouracil | 1 |
| controlled-trials | 1 |
| braf | 1 |
| bevacizumab | 1 |
| anti-egfr therapy | 1 |